[Predicting secondary malignancy in childhood cancer survivors using a new screening tool]

[Article in German]

Monika Sparber-Sauer^{1

2}

Affiliations

¹ Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder‑, Jugend- und Frauenmedizin, Pädiatrie 5 (Pädiatrische Onkologie, Hämatologie, Immunologie), Klinikum der Landeshauptstadt Stuttgart gKAöR, Stuttgart, Deutschland. m.sparber@klinikum-stuttgart.de.
² Medizinische Fakultät, Universität Tübingen, Tübingen, Deutschland. m.sparber@klinikum-stuttgart.de.

Comment

[Article in German]

Monika Sparber-Sauer. Strahlenther Onkol. 2022 Sep.

. 2022 Sep;198(9):866-868.

doi: 10.1007/s00066-022-01956-9. Epub 2022 May 28.

Monika Sparber-Sauer^{1

2}

¹ Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder‑, Jugend- und Frauenmedizin, Pädiatrie 5 (Pädiatrische Onkologie, Hämatologie, Immunologie), Klinikum der Landeshauptstadt Stuttgart gKAöR, Stuttgart, Deutschland. m.sparber@klinikum-stuttgart.de.
² Medizinische Fakultät, Universität Tübingen, Tübingen, Deutschland. m.sparber@klinikum-stuttgart.de.

No abstract available

Comment on

Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors.
Cullinan N, Schiller I, Di Giuseppe G, Mamun M, Reichman L, Cacciotti C, Wheaton L, Caswell K, Di Monte B, Gibson P, Johnston DL, Fleming A, Pole JD, Malkin D, Foulkes WD, Dendukuri N, Goudie C, Nathan PC. Cullinan N, et al. J Clin Oncol. 2021 Oct 10;39(29):3207-3216. doi: 10.1200/JCO.21.00018. Epub 2021 Aug 12. J Clin Oncol. 2021. PMID: 34383599

1. Turcotte LM, Liu Q, Yasui Y et al (2019) Chemotherapy and risk of subsequent malignant neoplasms in the childhood cancer survivor study cohort. J Clin Oncol 37(34):3310–3319 - DOI
1. Teepen JC, van Leeuwen FE, Tissing WJ et al (2017) Long-term risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER study cohort: role of chemotherapy. J Clin Oncol 35(20):2288–2298 - DOI
1. Meadows AT, Strong LC, Li FP et al (1980) Bone sarcoma as a second malignant neoplasm in children: influence of radiation and genetic predisposition for the late effects study group. Cancer 46(12):2603–2606 - DOI
1. Pole JD, Gu LY, Kirsh V, Greenberg ML, Nathan PC (2015) Subsequent malignant neoplasms in a population-based cohort of pediatric cancer patients: a focus on the first 5 years. Cancer Epidemiol Biomarkers Prev 24(10):1585–1592 - DOI
1. Pole JD, Darmawikarta D, Gassas A et al (2015) Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT. Bone Marrow Transplant 50(5):721–726 - DOI